Lima Filipe Rocha, de Paula Natália Aparecida, Simões Mateus Mendonça Ramos, Manso Gabriel Martins da Costa, Albertino Gustavo Sartori, Felisbino Giovani Cesar, Antunes Vanderson Mayron Granemann, Perecin Fernanda André Martins Cruz, Westin Andrezza Telles, Lugão Helena Barbosa, Frade Marco Andrey Cipriani
Healing and Hansen's Disease Laboratory, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Dermatology Division, Department of Internal Medicine, National Referral Center for Sanitary Dermatology and Hansen's Disease, Clinical Hospital of the Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Front Med (Lausanne). 2022 Aug 10;9:972244. doi: 10.3389/fmed.2022.972244. eCollection 2022.
The bacilloscopy of the slit-skin smear (SSS) is the exclusive laboratory test associated with dermato-neurological evaluation for Hansen's disease (HD) diagnosis; however, it is negative in the majority of PB or primary neural forms. Thus, a PCR technique involving different sequences and target genes has been performed with an aim to increase the sensitivity and specificity of identification, especially in patients with low bacillary loads. Additionally, serological assays based on antibody response reflect infection levels and indicate that this could be a simpler, less invasive technique for estimating exposure. Serological tests and PCR have been shown to be more sensitive and accurate than the SSS. Our study aimed to measure accuracy and performance among the SSS and PCR of dermal scrapings stored on filter paper and APGL-I serology for diagnosis in HD. A cross-sectional study analyzing the medical records ( = 345) of an HD outpatient-dermatology clinic from 2014 to 2021 was conducted. Accuracy performance parameters, correlation, and concordance were used to assess the value among the SSS, PCR, and APGL-I exams in HD. The SSS presented 24.5% sensitivity, 100% specificity, 37.4% accuracy, and the lowest negative predictive value (21.5%). The PCR assay had 41, 100, and 51% sensitivity, specificity, and accuracy, respectively. PCR and APGL-I serology increased the detection of HD cases by 16 and 20.6%, respectively. PCR was positive in 51.3% of patients when the SSS was negative. The SSS obtained moderate concordance with PCR [-value: 0.43 (CI: 0.33-0.55)] and APGL-I [-value: 0.41 (CI: 0.31-0.53)]. A moderate positive correlation was found between the APGL-I index and the bacillary index ( = 0.53; < 0.0001). Thus, the use of the SSS is a low sensitivity and accuracy method due to its low performance in HD detection. The use of PCR and serological tests allows for a more sensitive and accurate diagnosis of patients.
裂隙皮肤涂片(SSS)的细菌学检查是与麻风病(HD)诊断的皮肤神经学评估相关的唯一实验室检测;然而,在大多数结核样型(PB)或原发性神经型病例中,该检查结果为阴性。因此,已经开展了一种涉及不同序列和靶基因的聚合酶链反应(PCR)技术,以提高识别的敏感性和特异性,特别是对于细菌载量低的患者。此外,基于抗体反应的血清学检测反映了感染水平,并表明这可能是一种更简单、侵入性更小的估计暴露情况的技术。血清学检测和PCR已被证明比SSS更敏感、更准确。我们的研究旨在衡量用于HD诊断的滤纸保存的皮肤刮片的SSS和PCR以及麻风菌素-1(APGL-I)血清学检测的准确性和性能。我们进行了一项横断面研究,分析了2014年至2021年一家HD门诊皮肤科诊所的病历(n = 345)。使用准确性性能参数、相关性和一致性来评估HD中SSS、PCR和APGL-I检查的价值。SSS的敏感性为24.5%,特异性为100%,准确性为37.4%,阴性预测值最低(21.5%)。PCR检测的敏感性、特异性和准确性分别为41%、100%和51%。PCR和APGL-I血清学检测分别将HD病例的检出率提高了16%和20.6%。当SSS为阴性时,PCR在51.3%的患者中呈阳性。SSS与PCR的一致性中等[κ值:0.43(95%置信区间:0.33 - 0.55)],与APGL-I的一致性也中等[κ值:0.41(95%置信区间:0.31 - 0.53)]。在APGL-I指数和细菌指数之间发现了中等程度的正相关(r = 0.53;P < 0.0001)。因此,由于SSS在HD检测中的低性能,它是一种敏感性和准确性较低的方法。使用PCR和血清学检测能够对患者进行更敏感、准确的诊断。